Name: Wall Street gains on Boeing surge and coronavirus drug hopes
Brand: reuters.com
SKU: reuters-com-773
Availability: OnlineOnly

critic

Wall Street gains on Boeing surge and coronavirus drug hopes

preview

By (Reuters) - U.S. stocks rose on Friday and also posted gains for the week, boosted by a surge in Boeing shares, President Donald Trump’s plan to reopen the coronavirus-battered economy and hopes of a potential drug by Gilead to treat COVID-19.The Nasdaq added 6.1% for the week and registered its biggest two-week percentage gain since 2001.With no treatments or vaccines currently approved for the coronavirus, the news helped lift global equity markets. But Gilead said the totality of the data from the trial needed to be analyzed, and it expected to report results from a study testing the drug in severe COVID-19 patients at the end of April.“If you can ultimately get a powerful treatment in lieu of a vaccine in the next couple of months, that would be good for cyclical stocks, anything economically sensitive,” said R.J. Grant, head of trading at Keefe, Bruyette &amp; Woods in New York. “If we can get some sort of back-to-normal in some way that the economy could start to function, the banks are going to rip,” he added.The S&amp;P 500 is up nearly 30% from its March trough following a raft of global stimulus and hopes that the spread of the virus was nearing a peak in the United States.However, the S&amp;P remains about 15% off its all-time high, and strategists have warned of a deep economic slump from the halt in business activity and layoffs.Some U.S. states are expected to begin announcing timetables for lifting restrictions. On Thursday, Trump unveiled guidelines for a staggered, three-stage process by states to lift restrictions on business and social life to curb the pandemic.For the week, the Dow added 2.2% and the S&amp;P 500 rose 3%.The reopening guidelines “provide some hope and optimism for folks and the market and the whole economy. It’s a start,” said Gary Bradshaw, portfolio manager at Hodges Capital Management in Dallas.Bradshaw, who owns Boeing shares, said the planemaker’s news was positive as well. “I certainly haven’t given up on it,” he said.Volume on U.S. exchanges was 12.75 billion shares, compared to the 13.72 billion average for the full session over the last 20 trading days.Advancing issues outnumbered declining ones on the NYSE by a 5.18-to-1 ratio; on Nasdaq, a 3.88-to-1 ratio favored advancers.The S&amp;P 500 posted 10 new 52-week highs and no new lows; the Nasdaq Composite recorded 31 new highs and 13 new lows.Reporting by Caroline Valetkevitch; Additional reporting by Sinead Carew, Medha Singh and Akanksha Rana; Editing by Jonathan Oatis and Leslie AdlerOur Standards:

By (Reuters) - U.S. stocks rose on Friday and also posted gains for the week, boosted by a surge in Boeing shares, President Donald Trump’s plan to reopen the coronavirus-battered economy and hopes of a potential drug by Gilead to treat COVID-19.The Nasdaq added 6.1% for the week and registered its biggest two-week percentage gain since 2001.With no treatments or vaccines currently approved for the coronavirus, the news helped lift global equity markets. But Gilead said the totality of the data from the trial needed to be analyzed, and it expected to report results from a study testing the...

public

Caroline Valetkevitch

Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz.

reuters.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Wall Street gains on Boeing surge and coronavirus drug hopes

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS